Contract Variation Agreement No. 1 to the Managed Access Agreement - September 2021

NICE and NHS England have agreed with Alexion to extend the data collection period for the asfotase alfa managed access agreement to provide additional time for the collection of more data before NICE’s review. Access to treatment will continue for new and existing patients during any extension period agreed and the subsequent NICE review, after which NHS England will implement NICE’s updated recommendations. 

Download contract variation agreement No. 1

This page was last updated: